Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-10

Clinical Trial Update: A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating the effect of solifenacin on the Overactive Bladder Symptom Score in adults with overactive bladder; the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Over Active Bladder | Phase 4 | Status: COMPLETED